Cardiology Surgery Devices and Drugs Market Valued at $38.6 billion in 2025, Set to Grow at a 4.0% CAGR

Cardiology surgery devices and drugs market was valued at $38.6 billion in 2025 and is projected to reach $56.7 billion by 2035, growing at a CAGR of 4.0% during the forecast Period (2026-2035). FDA approval of a new transcatheter heart valve system for high-risk patients with severe aortic regurgitation signifies a shift towards minimally invasive cardiac procedures, aligning with market trends favoring advanced surgical devices that enhance patient outcomes. For instance, in March 2026, JenaValve received FDA approval for the Trilogy Transcatheter Heart Valve System, the first device specifically approved for treating symptomatic, severe aortic regurgitation (ssAR) in high-risk surgical patients in the US. This landmark approval addresses a critical need for effective treatment options for ssAR, which is often undertreated, affecting tens of thousands annually. The approval is based on results from the ALIGN-AR Pivotal Trial, demonstrating the system's safety and efficacy in this patient population.

Browse the full report description of “Cardiology Surgery Devices and Drugs Market Size, Share & Trends Analysis by Type (Cardiology Surgery, Cardiology Devices, and Cardiology Drugs), By Application (Coronary Artery Disease, Heart Failure, Arrhythmia, Heart Valve Disorders, and Others), and By End-User (Hospitals, Diagnostic Centres, and Research Institutes), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/cardiology-surgery-devices-and-drugs-market

FDA Clears AI-Guided Cardiac Tools and Advanced Pacing Solutions

• In March 2026, Philips received FDA clearance for its DeviceGuide software, which utilizes AI to assist physicians by providing real-time visual support during mitral valve repair procedures, specifically for mitral regurgitation. This AI-driven tool leverages Philips' EchoNavigator technology, integrating live echocardiography and X-ray images. Collaboratively developed with Edwards Lifesciences, DeviceGuide aims to enhance workflows in mitral transcatheter edge-to-edge repair (M-TEER) treatments.
• In March?2026, the OmniaSecure defibrillation lead received FDA approval in March?2026 for placement in the left bundle branch (LBB) area, enabling conduction system pacing with defibrillation capability. This makes it the first defibrillation lead approved for this physiological pacing approach, improving outcomes for patients requiring both pacing and defibrillation support.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Therapeutic Type
  • By Drug Form
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Abbott Laboratories, Boston Scientific Corp., Johnson & Johnson (J&J) MedTech, Medtronic plc, among others

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cardiology Surgery Devices and Drugs Market Report Segment

By Type

• Cardiology Surgery
• Cardiology Devices
• Cardiology Drugs

By Application

• Coronary Artery Disease
• Heart Failure
• Arrhythmia
• Heart Valve Disorders
• Others

By End?User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Cardiac Clinics
• Others

By End-User

• Hospital-based Distribution
• Retail Pharmacies / Drug Stores
• Online Pharmacies / E-commerce Platforms
• Clinics & Specialty Centers
• Others

Global Cardiology Surgery Devices and Drugs Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cardiology-surgery-devices-and-drugs-market